Absence of hypodiploidy and/or chromosome 13 abnormalities (hypo-CA13) confers superior survival in multiple myeloma (MM) patients (pts): Interim analysis of total therapy (TT) II trial

Fassas, A. B. T., Sawyer, J., McCoy, J., Anaissie, E. J., Lee, C. K., Talamo, G., Wendling, C., Zangari, M., Van Rhee, F., Thertulien, R., Tricot, G. J. and Barlogie, B. (2003). Absence of hypodiploidy and/or chromosome 13 abnormalities (hypo-CA13) confers superior survival in multiple myeloma (MM) patients (pts): Interim analysis of total therapy (TT) II trial. In: 45th Annual Meeting of the American Society of Hematology, San Diego CA, United States, (684A-684A). 6-9 December 2003.

Author Fassas, A. B. T.
Sawyer, J.
McCoy, J.
Anaissie, E. J.
Lee, C. K.
Talamo, G.
Wendling, C.
Zangari, M.
Van Rhee, F.
Thertulien, R.
Tricot, G. J.
Barlogie, B.
Title of paper Absence of hypodiploidy and/or chromosome 13 abnormalities (hypo-CA13) confers superior survival in multiple myeloma (MM) patients (pts): Interim analysis of total therapy (TT) II trial
Conference name 45th Annual Meeting of the American Society of Hematology
Conference location San Diego CA, United States
Conference dates 6-9 December 2003
Journal name Blood   Check publisher's open access policy
Place of Publication Washington, DC, United States
Publisher American Society of Hematology
Publication Year 2003
Sub-type Published abstract
ISSN 0006-4971
1528-0020
Volume 102
Issue 11
Start page 684A
End page 684A
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Access Statistics: 60 Abstract Views  -  Detailed Statistics
Created: Mon, 14 Mar 2011, 10:19:41 EST